Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.

Sharma A, Gokulchandran N, Sane H, Nagrajan A, Paranjape A, Kulkarni P, Shetty A, Mishra P, Kali M, Biju H, Badhe P

DOI: 10.1155/2013/623875
Published: 2013
Container: Stem cells international
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/2013/623875,
  title = {Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.},
  author = {Sharma A and Gokulchandran N and Sane H and Nagrajan A and Paranjape A and Kulkarni P and Shetty A and Mishra P and Kali M and Biju H and Badhe P},
  year = {2013},
  journal = {Stem cells international},
  doi = {10.1155/2013/623875},
  url = {https://doi.org/10.1155/2013/623875}
}

RIS

TY  - JOUR
TI  - Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.
AU  - Sharma A
AU  - Gokulchandran N
AU  - Sane H
AU  - Nagrajan A
AU  - Paranjape A
AU  - Kulkarni P
AU  - Shetty A
AU  - Mishra P
AU  - Kali M
AU  - Biju H
AU  - Badhe P
PY  - 2013
JO  - Stem cells international
DO  - 10.1155/2013/623875
UR  - https://doi.org/10.1155/2013/623875
ER  -

APA

A, S., N, G., H, S., A, N., A, P., P, K., A, S., P, M., M, K., H, B., & P, B. (2013). Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.. Stem cells international. https://doi.org/10.1155/2013/623875

Source records

pubmed · retrieved 2026-09-26T11:31:53.261Z